UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$351M |
| 2 |
Cisco
CSCO
|
+$313M |
| 3 |
Coca-Cola
KO
|
+$283M |
| 4 |
Estee Lauder
EL
|
+$268M |
| 5 |
TUYA
Tuya Inc
TUYA
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.16B |
| 2 |
TAL Education Group
TAL
|
+$1.92B |
| 3 |
Alibaba
BABA
|
+$1.88B |
| 4 |
Procter & Gamble
PG
|
+$640M |
| 5 |
New Oriental
EDU
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.72% |
| 2 | Healthcare | 12.81% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
2476
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $514K | ﹤0.01% |
81,440
+2,589
| +3% | +$16.7K |
|
2477
John B. Sanfilippo & Son
JBSS
$986M
| $511K | ﹤0.01% |
5,765
+494
| +9% | +$44.9K |
|
|
ACRE
2478
Ares Commercial Real Estate
ACRE
$247M
| $510K | ﹤0.01% |
34,694
+5,494
| +19% | +$82.3K |
|
2479
Amneal Pharmaceuticals
AMRX
$6.1B
| $507K | ﹤0.01% |
98,985
+12,036
| +14% | +$68.4K |
|
|
ABTX
2480
DELISTED
Allegiance Bancshares
ABTX
| $505K | ﹤0.01% |
13,132
+7,355
| +127% | +$297K |
|
2481
REX American Resources
REX
$1.39B
| $505K | ﹤0.01% |
33,570
+16,116
| +92% | +$234K |
|
2482
iShares MSCI Turkey ETF
TUR
$201M
| $504K | ﹤0.01% |
23,964
-7,200
| -23% | -$166K |
|
2483
McEwen Inc
MUX
$1B
| $502K | ﹤0.01% |
36,377
+275
| +0.8% | +$3.64K |
|
2484
Byline Bancorp
BY
$1.78B
| $502K | ﹤0.01% |
+22,170
| New | +$496K |
|
|
ICPT
2485
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $501K | ﹤0.01% |
25,109
+12,478
| +99% | +$247K |
|
2486
Insteel Industries
IIIN
$592M
| $501K | ﹤0.01% |
15,581
-1,430
| -8% | -$49.4K |
|
|
RADI
2487
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $499K | ﹤0.01% |
+34,393
| New | +$514K |
|
2488
Comstock Resources
CRK
$3.7B
| $498K | ﹤0.01% |
+74,708
| New | +$430K |
|
|
ORLA
2489
Orla Mining
ORLA
$3.36B
| $498K | ﹤0.01% |
120,400
+46,800
| +64% | +$194K |
|
|
FLXN
2490
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $497K | ﹤0.01% |
60,406
+12,222
| +25% | +$104K |
|
|
LORL
2491
DELISTED
Loral Space and Communications, Inc.
LORL
| $495K | ﹤0.01% |
12,746
+867
| +7% | +$32.9K |
|
2492
Rhythm Pharmaceuticals
RYTM
$7.31B
| $494K | ﹤0.01% |
25,215
+14,719
| +140% | +$306K |
|
|
OGI
2493
Organigram Holdings
OGI
$131M
| $490K | ﹤0.01% |
42,750
+3,625
| +9% | +$41.3K |
|
2494
Origin Bancorp
OBK
$1.7B
| $488K | ﹤0.01% |
11,500
+2,800
| +32% | +$121K |
|
2495
Winmark
WINA
$1.2B
| $487K | ﹤0.01% |
2,534
+205
| +9% | +$39.9K |
|
2496
Compugen
CGEN
$212M
| $486K | ﹤0.01% |
58,650
-14,500
| -20% | -$118K |
|
2497
Caesarstone
CSTE
$69.5M
| $486K | ﹤0.01% |
32,900
| – | – |
|
2498
Mercer International
MERC
$40.5M
| $485K | ﹤0.01% |
38,028
+8,785
| +30% | +$130K |
|
2499
Ecovyst
ECVT
$1.32B
| $484K | ﹤0.01% |
31,509
-27,175
| -46% | -$429K |
|
2500
Scholar Rock
SRRK
$5.88B
| $484K | ﹤0.01% |
16,739
+1,506
| +10% | +$46.1K |
|
Similar funds
UBS AM's Q2 2021 Portfolio in Review
As of Q2 2021, UBS AM held 2,827 positions worth $234B, up 3.3% from $226B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM withdrew a net $11.4B in Q2 2021, closing 76 positions and reducing 923 holdings. Its most notable exit was Seagate, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Vanguard Short-Term Treasury ETF worth $350M.
- UBS AM's largest Q2 2021 buy was Vanguard Short-Term Treasury ETF: 5,703,693 shares worth $350M.
- UBS AM added most to Cisco in Q2 2021, an estimated $313M increase.
- UBS AM's biggest Q2 2021 reduction was Microsoft, cutting an estimated $3.16B.
- UBS AM fully exited Seagate in Q2 2021, selling an estimated $107M.
- UBS AM's ten largest holdings make up 21% of its $234B portfolio in Q2 2021.
- UBS AM opened 239 new positions and closed 76 in Q2 2021.
- UBS AM's portfolio value rose 3.3% quarter-over-quarter to $234B.
Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.